R
Rolley E. Johnson
Researcher at Johns Hopkins University
Publications - 96
Citations - 7136
Rolley E. Johnson is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Buprenorphine & Methadone. The author has an hindex of 41, co-authored 96 publications receiving 6850 citations. Previous affiliations of Rolley E. Johnson include Johns Hopkins University School of Medicine & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Rolley E. Johnson,Mary Ann Chutuape,Eric C. Strain,Sharon L. Walsh,Maxine L. Stitzer,George E. Bigelow +5 more
TL;DR: As compared with low-dose methadone, levomethadyl acetate, buprenorphine, and high-dose Methadone substantially reduce the use of illicit opioids.
Journal ArticleDOI
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
TL;DR: Buprenorphine was as effective as methadone, 60 mg/d, and both were superior to methad one, 20 mg/D, in reducing illicit opioid use and maintaining patients in treatment for 25 weeks.
Journal ArticleDOI
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Hendrée E. Jones,Rolley E. Johnson,Donald R. Jasinski,Kevin E. O'Grady,Christian A. Chisholm,Robin E. Choo,Michael Crocetti,Robert A. Dudas,Cheryl Harrow,Marilyn A. Huestis,Lauren M. Jansson,Michael E. Lantz,Barry M. Lester,Lorraine Milio +13 more
TL;DR: Results suggest that buprenorphine is not inferior to methadone on outcome measures assessing NAS and maternal and neonatal safety when administered starting in the second trimester of pregnancy.
Journal ArticleDOI
A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
Warren K. Bickel,Warren K. Bickel,Maxine L. Stitzer,Maxine L. Stitzer,George E. Bigelow,George E. Bigelow,Ira A. Liebson,Ira A. Liebson,Donald R. Jasinski,Donald R. Jasinski,Rolley E. Johnson,Rolley E. Johnson +11 more
TL;DR: The results of this clinical trial indicated that buprenorphine was acceptable to patients and as effective as methadone in the detoxification treatment of heroin addicts.
Journal ArticleDOI
Buprenorphine: considerations for pain management.
TL;DR: Buprenorphine, a partial mu-opioid agonist which has been in clinical use for over 25 years, has been found to be amenable to new formulation technology based on its physiochemical and pharmacological profile.